• レポートコード:MRC2110B033 • 出版社/出版日:Persistence Market Research / 2021年9月30日 • レポート形態:英文、PDF、239ページ • 納品方法:Eメール • 産業分類:医療 |
Individual User | ¥725,200 (USD4,900) | ▷ お問い合わせ |
Multi User | ¥1,124,800 (USD7,600) | ▷ お問い合わせ |
Corporate User | ¥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、新型コロナウイルス感染症唾液採取キットの世界市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症による危機分析、需要分析・予測、価格分析、用途別(研究、診断)分析、エンドユーザー別(診断研究所、病院&クリニック、学術・研究機関、長期介護施設、在宅医療)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症による危機分析 ・需要分析・予測 ・価格分析 ・新型コロナウイルス感染症唾液採取キットの世界市場規模:用途別(研究、診断) ・新型コロナウイルス感染症唾液採取キットの世界市場規模:エンドユーザー別(診断研究所、病院&クリニック、学術・研究機関、長期介護施設、在宅医療) ・新型コロナウイルス感染症唾液採取キットの世界市場規模:地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
COVID-19 Saliva Collection Kits Market – Scope of Report
The latest publication by Persistence Market Research on the global COVID-19 saliva collection kits market evaluates the opportunities and current market landscape that provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for COVID-19 saliva collection kits and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the COVID-19 saliva collection kits market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the COVID-19 saliva collection kits industry are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, with the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the COVID-19 saliva collection kits market offers information divided into three important segments — application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
[Application]
COVID-19 Research
COVID-19 Diagnostics
[End User]
Diagnostic Laboratories
Hospitals & Clinics
Academic and Research Institutes
Biopharma Companies
Long-term Care Facilities
Home Care Settings
Others
[Region]
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Technology Innovation / Development Trends
4. Key Success Factors
4.1. Disease epidemiology
4.2. New launches and approvals
4.3. Regulatory Scenario / emergency authorization
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure Outlook
5.1.3. Increasing Research & Development Funding
5.2. Forecast Factors – Relevance & Impact
5.2.1. Increasing incidences of COVID-19 Infection
5.2.2. Growing demand of early and accurate disease diagnosis
5.2.3. Advancement in clinical diagnostic techniques
5.2.4. Rising investment in R&D
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 Economic analysis
6.4. COVID19 and Impact Analysis
6.5. 2020 Market Scenario
6.6. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global COVID-19 Saliva Collection Kits Market Demand (in Volume ‘000 Units) Analysis and Forecast, 2021–2031
7.1. Current and Future Market Volume (‘000 Units) Projections, 2021-2031
7.1.1. Y-o-Y Growth Trend Analysis
8. Global COVID-19 Saliva Collection Kits Market – Pricing Analysis
8.1. Regional Pricing Analysis, By Covid -19 Saliva Collection Kits
8.2. Global Average Pricing Analysis Benchmark
9. Global COVID-19 Saliva Collection Kits Market Demand Value (US$ Mn) Analysis and Forecast, 2021–2031
9.1. Current and Future Market Value (US$ Mn) Projections, 2021–2031
9.1.1. Y-o-Y Growth Trend Analysis
9.1.2. Absolute $ Opportunity Analysis
10. Global COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031, By Application
10.1. Introduction / Key Findings
10.2. Current and Future Market (US$ Mn) Analysis and Forecast By Application, 2021–2031
10.2.1. COVID-19 Research
10.2.2. COVID-19 Diagnostics
10.3. Market Attractiveness Analysis By Application
11. Global COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031, By End User
11.1. Introduction / Key Findings
11.2. Current and Future Market (US$ Mn) Analysis and Forecast By End User, 2021–2031
11.2.1. Diagnostic Laboratories
11.2.2. Hospitals & Clinics
11.2.3. Academic and research Institutes
11.2.4. Long Term Care Facilities
11.2.5. Home Care Settings
11.2.6. Airports
11.2.7. Others
11.3. Market Attractiveness Analysis By End User
12. Global COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031, by Region
12.1. Introduction
12.2. Current Market (US$ Mn) Analysis and Forecast By Region, 2021–2031
12.2.1. North America
12.2.2. Latin America
12.2.3. Europe
12.2.4. East Asia
12.2.5. South Asia
12.2.6. Oceania
12.2.7. Middle East and Africa (MEA)
12.3. Market Attractiveness Analysis By Region
13. North America COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031
13.1. Introduction
13.2. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
13.2.1. By Country
13.2.1.1. U.S.
13.2.1.2. Canada
13.2.2. By Application
13.2.3. By End User
13.3. Market Attractiveness Analysis
13.4. Key Market Participants – Intensity Mapping
14. Latin America COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031
14.1. Introduction
14.2. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
14.2.1. By Country
14.2.1.1. Brazil
14.2.1.2. Mexico
14.2.1.3. Argentina
14.2.1.4. Rest of Latin America
14.2.2. By Application
14.2.3. By End User
14.3. Market Attractiveness Analysis
14.4. Key Market Participants – Intensity Mapping
15. Europe COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031
15.1. Introduction
15.2. Market Value (US$ Mn) Forecast By Market Taxonomy2021–2031
15.2.1. By Country
15.2.1.1. Germany
15.2.1.2. Italy
15.2.1.3. France
15.2.1.4. U.K.
15.2.1.5. Spain
15.2.1.6. BENELUX
15.2.1.7. Russia
15.2.1.8. Rest of Europe
15.2.2. By Application
15.2.3. By End User
15.3. Market Attractiveness Analysis
15.4. Key Market Participants – Intensity Mapping
16. South Asia COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031
16.1. Introduction
16.2. Market Value (US$ Mn) Forecast By Market Taxonomy2021–2031
16.2.1. By Country
16.2.1.1. India
16.2.1.2. Thailand
16.2.1.3. Indonesia
16.2.1.4. Malaysia
16.2.1.5. Rest of South Asia
16.2.2. By Application
16.2.3. By End User
16.3. Market Attractiveness Analysis
16.4. Key Market Participants – Intensity Mapping
17. East Asia COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031
17.1. Introduction
17.2. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
17.2.1. By Country
17.2.1.1. China
17.2.1.2. Japan
17.2.1.3. South Korea
17.2.2. By Product
17.2.3. By Technology
17.2.4. By Application
17.2.5. By End User
17.3. Market Attractiveness Analysis
17.4. Key Market Participants – Intensity Mapping
18. Oceania COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031
18.1. Introduction
18.2. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
18.2.1. By Country
18.2.1.1. Australia
18.2.1.2. New Zealand
18.2.2. By Application
18.2.3. By End User
18.3. Market Attractiveness Analysis
18.4. Key Market Participants – Intensity Mapping
19. Middle East and Africa COVID-19 Saliva Collection Kits Market Analysis and Forecast 2021–2031
19.1. Introduction
19.2. Historical Market Value (US$ Mn) Trend Analysis By Value Taxonomy, 2016–2020
19.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021–2031
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. South Africa
19.3.1.4. Rest of Middle East and Africa
19.3.2. By Application
19.3.3. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants – Intensity Mapping
20. Key & Emerging Countries COVID-19 Saliva Collection Kits Market Value (US$ Mn) Analysis and Forecast 2021–2031
20.1. U.S. COVID-19 Saliva Collection Kits Market Analysis
20.1.1. By Application
20.1.2. By End User
20.2. Canada COVID-19 Saliva Collection Kits Market Analysis
20.2.1. By Application
20.2.2. By End User
20.3. Brazil COVID-19 Saliva Collection Kits Market Analysis
20.3.1. By Application
20.3.2. By End User
20.4. Mexico COVID-19 Saliva Collection Kits Market Analysis
20.4.1. By Application
20.4.2. By End User
20.5. Argentina COVID-19 Saliva Collection Kits Market Analysis
20.5.1. By Application
20.5.2. By End User
20.6. U.K. COVID-19 Saliva Collection Kits Market Analysis
20.6.1. By Application
20.6.2. By End User
20.7. Germany COVID-19 Saliva Collection Kits Market Analysis
20.7.1. By Application
20.7.2. By End User
20.8. France COVID-19 Saliva Collection Kits Market Analysis
20.8.1. By Application
20.8.2. By End User
20.9. Italy COVID-19 Saliva Collection Kits Market Analysis
20.9.1. By Application
20.9.2. By End User
20.10. Spain COVID-19 Saliva Collection Kits Market Analysis
20.10.1. By Application
20.10.2. By End User
20.11. BENELUX COVID-19 Saliva Collection Kits Market Analysis
20.11.1. By Application
20.11.2. By End User
20.12. Russia COVID-19 Saliva Collection Kits Market Analysis
20.12.1. By Application
20.12.2. By End User
20.13. China COVID-19 Saliva Collection Kits Market Analysis
20.13.1. By Application
20.13.2. By End User
20.14. Japan COVID-19 Saliva Collection Kits Market Analysis
20.14.1. By Application
20.14.2. By End User
20.15. South Korea COVID-19 Saliva Collection Kits Market Analysis
20.15.1. By Application
20.15.2. By End User
20.16. ASEAN COVID-19 Saliva Collection Kits Market Analysis
20.16.1. By Application
20.16.2. By End User
20.17. Australia COVID-19 Saliva Collection Kits Market Analysis
20.17.1. By Application
20.17.2. By End User
20.18. New Zealand COVID-19 Saliva Collection Kits Market Analysis
20.18.1. By Application
20.18.2. By End User
20.19. Turkey COVID-19 Saliva Collection Kits Market Analysis
20.19.1. By Application
20.19.2. By End User
20.20. GCC Countries COVID-19 Saliva Collection Kits Market Analysis
20.20.1. By Application
20.20.2. By End User
20.21. South Africa COVID-19 Saliva Collection Kits Market Analysis
20.21.1. By Application
20.21.2. By End User
21. Market Structure Analysis
21.1. Market Concentration
21.2. Market Presence Analysis
21.2.1. Regional footprint of Players
21.2.2. Product foot print by Players
21.2.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Deep Dive
22.2.1. Thermo Fisher scientific
22.2.1.1. Overview
22.2.1.2. Product Portfolio
22.2.1.3. Profitability by Market Segments (Product/End User/Region)
22.2.1.4. Sales Footprint
22.2.1.5. Strategy Overview
22.2.1.5.1. Marketing Strategy
22.2.1.5.2. Product Strategy
22.2.1.5.3. End User Strategy
22.2.2. ACON Laboratories, Inc
22.2.2.1. Overview
22.2.2.2. Product Portfolio
22.2.2.3. Profitability by Market Segments (Product/End User/Region)
22.2.2.4. Sales Footprint
22.2.2.5. Strategy Overview
22.2.2.5.1. Marketing Strategy
22.2.2.5.2. Product Strategy
22.2.2.5.3. End User Strategy
22.2.3. KYODO INTERNATIONAL INC.
22.2.3.1. Overview
22.2.3.2. Product Portfolio
22.2.3.3. Profitability by Market Segments (Product/End User/Region)
22.2.3.4. Sales Footprint
22.2.3.5. Strategy Overview
22.2.3.5.1. Marketing Strategy
22.2.3.5.2. Product Strategy
22.2.3.5.3. End User Strategy
22.2.4. Lucence Health INc
22.2.4.1. Overview
22.2.4.2. Product Portfolio
22.2.4.3. Profitability by Market Segments (Product/End User/Region)
22.2.4.4. Sales Footprint
22.2.4.5. Strategy Overview
22.2.4.5.1. Marketing Strategy
22.2.4.5.2. Product Strategy
22.2.4.5.3. End User Strategy
22.2.5. Vitagene
22.2.5.1. Overview
22.2.5.2. Product Portfolio
22.2.5.3. Profitability by Market Segments (Product/End User/Region)
22.2.5.4. Sales Footprint
22.2.5.5. Strategy Overview
22.2.5.5.1. Marketing Strategy
22.2.5.5.2. Product Strategy
22.2.5.5.3. End User Strategy
22.2.6. Therma Bright Inc
22.2.6.1. Overview
22.2.6.2. Product Portfolio
22.2.6.3. Profitability by Market Segments (Product/End User/Region)
22.2.6.4. Sales Footprint
22.2.6.5. Strategy Overview
22.2.6.5.1. Marketing Strategy
22.2.6.5.2. Product Strategy
22.2.6.5.3. End User Strategy
22.2.7. Norgen Biotek Corp.
22.2.7.1. Overview
22.2.7.2. Product Portfolio
22.2.7.3. Profitability by Market Segments (Product/End User/Region)
22.2.7.4. Sales Footprint
22.2.7.5. Strategy Overview
22.2.7.5.1. Marketing Strategy
22.2.7.5.2. Product Strategy
22.2.7.5.3. End User Strategy
22.2.8. NeuMoDx Molecular, Inc.
22.2.8.1. Overview
22.2.8.2. Product Portfolio
22.2.8.3. Profitability by Market Segments (Product/End User/Region)
22.2.8.4. Sales Footprint
22.2.8.5. Strategy Overview
22.2.8.5.1. Marketing Strategy
22.2.8.5.2. Product Strategy
22.2.8.5.3. End User Strategy
22.2.9. Zymo Research Corporation.
22.2.9.1. Overview
22.2.9.2. Product Portfolio
22.2.9.3. Profitability by Market Segments (Product/End User/Region)
22.2.9.4. Sales Footprint
22.2.9.5. Strategy Overview
22.2.9.5.1. Marketing Strategy
22.2.9.5.2. Product Strategy
22.2.9.5.3. End User Strategy
22.2.10. Salimetrics
22.2.10.1. Overview
22.2.10.2. Product Portfolio
22.2.10.3. Profitability by Market Segments (Product/End User/Region)
22.2.10.4. Sales Footprint
22.2.10.5. Strategy Overview
22.2.10.5.1. Marketing Strategy
22.2.10.5.2. Product Strategy
22.2.10.5.3. End User Strategy
22.2.11. NEST Scientific USA
22.2.11.1. Overview
22.2.11.2. Product Portfolio
22.2.11.3. Profitability by Market Segments (Product/End User/Region)
22.2.11.4. Sales Footprint
22.2.11.5. Strategy Overview
22.2.11.5.1. Marketing Strategy
22.2.11.5.2. Product Strategy
22.2.11.5.3. End User Strategy
22.2.12. Mawi DNA Technologies
22.2.12.1. Overview
22.2.12.2. Product Portfolio
22.2.12.3. Profitability by Market Segments (Product/End User/Region)
22.2.12.4. Sales Footprint
22.2.12.5. Strategy Overview
22.2.12.5.1. Marketing Strategy
22.2.12.5.2. Product Strategy
22.2.12.5.3. End User Strategy
23. Assumptions and Acronyms Used
24. Research Methodology